5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with triphenyltetrazolium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, H; Harada, K; Honmou, O; Houkin, K; Kocsis, JD; Onda, T | 1 |
| Harada, K; Honmou, O; Houkin, K; Kocsis, JD; Omori, Y; Suzuki, J | 1 |
2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and triphenyltetrazolium
| Article | Year |
|---|---|
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia.
Topics: Adenoviridae; Angiopoietin-1; Animals; Brain Ischemia; Coloring Agents; Exercise Test; Galactosides; Genetic Therapy; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Indoles; Infarction, Middle Cerebral Artery; Injections, Intravenous; Magnetic Resonance Imaging; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Neovascularization, Physiologic; Rats; Tetrazolium Salts | 2008 |
Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats.
Topics: Analysis of Variance; Animals; Brain Infarction; Brain Ischemia; Capillaries; Clinical Protocols; Disease Models, Animal; Female; Galactosides; Humans; Indoles; Injections, Intravenous; Magnetic Resonance Imaging; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Motor Activity; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Time Factors; Transplantation, Heterologous | 2008 |